NCT05000294 2026-06-05Atezolizumab Plus Tivozanib in Immunologically Cold Tumor TypesUniversity of FloridaPhase 1/2 Recruiting29 enrolled
NCT01972516 2017-06-05Tivozanib As Maintenance Therapy In GYNDana-Farber Cancer InstitutePhase 2 Terminated4 enrolled 7 charts